Moreover, using the existing immunotherapy data about PD1 and CTLA‐4 of HCC in the database, showing the immunotherapy of high CS group was positive response to CTLA‐4(+)/PD1(−) and CTLA‐4(−)/PD1(−). Here, CTLA4 is linked to hepatocellular carcinoma.